Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Glymide tablets (5 mg glibenclamide) Produced by Julphar / UAE versus Daonil® tablets (5 mg glibenclamide) Produced Sanofi-Aventis / Germany, in healthy subjects under fed condition.

drug protocol number
13-2017
drug sponsor
SFDA
drug study
Glymide
drug trial site
Saudi Ajal
drug status
Ongoing
drug phase